Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, the warrants are worthless. They’ll never come close to the exercise price.
You have got to be kidding. ITOX has 4 part-time employees and has generated revenues of about $10,000 a month in CY20.
Since the CEO and his associates took over management of ITOX, the stock has dropped more than 99%.
There’s not much, if anything, left.
Someone trying to prop up the price with a $320 purchase.
AAAAMHIM would still maintain that the low outstanding share count is good reason to invest in ITOX. That faulty rationale will still exist when the pps falls to $0.005 or less.
Conference call to announce 3Q earnings will be held on October 22.
That’s early. Twenty four days prior to required date. Interesting.
What is the current status of the business relationship between Sigma and Siemens?
This will soon dip below .009.
To be expected given virtually no news, insignificant revenues and 4 part-time employees, including 3 officers who are relying on the sale of ITOX securities for their compensation.
Why is that disappointing? You’ve seen and heard about the pricing. What did you expect for a single unit?
Sure, no big deal. Just dilute shareholders in order to funnel money for unwarranted consultant fees to the part time officers of the company
Seems like there will be a significant addressable market for PR3D Lite.
In time, we will learn more about the pricing model. Wonder if there will be residuals for Lite as there is for the larger more complex systems.
Wouldn’t the dollar figure be dependent on the number of machines Coherent sells with PrintRite 3D Lite installed ?
I have again viewed the video from the Sept 29 webinar.
At the 30:10 mark Darren Beckett states “...on the end user side, we have obviously Airbus and Baker Hughes who are in production using this technology for in process quality assurance.”
I was not aware of any previous acknowledgment that Airbus was actually employing PR3D.
This means there is now confirmation of sales to 3 big end users - Mitsubishi, Baker Hughes and Airbus.
You would think the market would take better note of these positive developments.
Recent deals with:
Additive Industries
DMG Mori
Mitsubishi
Baker Hughes
Airbus
When is this (and the patent portfolio) going to be reflected in Sigma’s market cap?
SIgma is grossly undervalued and unappreciated. One of these days there should be recognition and a massive adjustment.
I thought Ron Fisher and Darren Beckett made a very good presentation In the webinar earlier today. I hope to be able to review it again because I thought I heard Darren make reference to installations by Baker Hughes and Airbus. I know Sigma has been working with Airbus, but I did not know Airbus had actually purchased a PR3D system.
There was a lot of good info and Q&A on the webinar. Hope it will soon be available for replay.
Happy Birthday ! Where are you celebrating the occasion?
Maybe you’d have better luck reaching Cliff at AHI or Cambridge MedSpace, the two private companies he is involved in.
I don’t think ITOX will close below
$0.0058 this week.
I suggest you read the latest 10-k and 10-q in detail. Good luck but beware.
The revenues, actually the lack of revenues, and the part-time status of the officers-employees and the fact that no one answers the phones or returns emails should indicate that ITOX is basically a shell with a lot of hype and unsubstantiated boasts.
I’m just curious as to what your point is in posting these bios.
Cliff and Karen left out the schools from which they obtained their degrees.
It’s no big deal. Just surprising when the bios are self-written or self-edited.
Looks like “Rembrandt” had to step up and invest $10.20 so that ITOX would not close below $0.01.
Page 20 of the recently filed 10-Q for 2Q of 2020 states that ITOX now rents its office space from a shareholder on a month to month basis for $250.00 per month.
Part time employees who don’t answer the phone or respond to emails or generate any significant revenue for the company obviously don’t need much space or an impressive office suite.
Thank you for sharing this clarification. It helps.
Silver, I always appreciate your perspective.
If I recall correctly, some time ago you stated you thought Sigma’s market cap should reach 250-300 M.
I know a lot has transpired since then, but I would be interested in knowing if you still hold similar thoughts about Sigma’s intermediate term value.
Thanks for all your insight over the years.
Ted, I acknowledge your point, but by that rationale, there is not much point in Sigma even bothering with PR.
The audience is small in either case, but I suspect more read the press releases than they do the SEC filings. Granted, that is not to their credit.
I’m not disagreeing with you. Just frustrated over the apparent lack of awareness by investors.
Take care.
I realize that but I thought the developments with Baker Hughes and DMG Mori warranted highlighting in a PR separate from simply being contained in the many slides in the new 8-k.
Mark did address this in the webinar yesterday but I suspect that had a rather limited audience.
I viewed the presentation, but I am surprised that Sigma and MZ have not issued a PR to announce the sale to Baker Hughes and the certification by DMG Mori.
The webinar yesterday was good, but I don’t imagine it was viewed by many.
Really disappointing that market cap and pps remain in the doldrums after recent sales to Mitsubishi and Baker Hughes and certifications by Additive Industries and DMG Mori.
The certification by DMG Mori and the sale of one unit to Baker Hughes were both mentioned by Ruport in the webinar yesterday and included in the new slide presentation in the latest SEC filing
C’mon. A bio on LinkedIn means nothing. An individual can post whatever profile he wants. Claims are not verifiable. Many times just a lot of fluff or “fake news.”
As Southern Gal posted, name two emerging growth companies that Cliff has taken to the next level.
There are no facts that support your boast.
Yes, and the answer is zero. Cliff has not yet demonstrated that he can take an emerging growth company to the next level. This is well indicated by the pps falling to $0.01 and revenues for the first 2 quarters of 2020 totaling less than $50,000.
Charts and posts indicate the price of this stock was about $0.26 not too long ago and over $3.00 at one time.
It is not “emerging.” It is sinking !
Don’t know circumstances of Cliff’s departure from Medtronic.
History of ITOX indicates Cliff was not the founder of this “emerging company.” He became CEO and CFO and CTO of ITOX in 2018 and now works for ITOX on part-time basis for $48 an hour plus stock awards and stock options.
ITOX is a sales agent for Aingura. Nothing more.
What emerging companies has Cliff taken to the next level?
Would be indication as to how much time and effort Cliff spends on ITOX relative to his other ownership interests (AHI and Cambridge MedSpace) and where the revenues flow.
Maybe the other companies which Cliff owns - AHI and Cambridge MedSpace - are doing better.
ITOX shareholders and other prospective investors in the company may want to consider the following in doing their due diligence.
1. The 10-k for fiscal year 2019 which ITOX filed on June 23, 2020, states (p. 33) that the company “...did not maintain effective internal control over financial reporting as of December 31, 2019.”
The 10-k goes on to state that
“...due to lack of resources, we were unable to execute the complete remediation plan” that was proposed to address the material weaknesses initially disclosed in the 2018 10-k.
2. Page 35 of the 10-k states that
“Mr. Emmons is also the founder of AHI, LLC, a consultancy firm.”
3. Pages 43-44 of the 10-k detail a number of financial transactions between ITOX and “Cambridge MedSpace LLC, an entity of which Mr. Emmons is an owner.
4. AHI and Cambridge MedSpace are not public companies and are not required to disclose their financial dealings. But it would be interesting and instructive to know how much time Mr. Emmons devotes to those companies and how much revenue he generates for them. We know ITOX received only $15,000 in the 1Q of 2020 from the efforts of Mr. Emmons and his associates. Maybe AHI and Cambridge did better.
The SEC filings indicate that ALL of the ITOX employees are part-time. That may be why no one answers the phone or responds to emails.
IMO a merger would not be beneficial to either company and is extremely unlikely.
It would seemingly limit Sigma’s market to those printers produced by AI and would really restrict Sigma’s growth.
As for AI, it can now offer PR3D for its printers so a merger would not necessarily generate the sale of more AI printers.
Thank you. That is good to know in assessing the Sigma - AI relationship.
Thanks. I thought maybe there was an industry site that might recap all printers sold by various OEM throughout the world.